| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 4 |
| 1 | AMBRISENTAN | 3 |
| 2 | EPOPROSTENOL | 3 |
| 3 | SILDENAFIL | 3 |
| 4 | AMLODIPINE | 2 |
| 5 | PREDNISOLONE | 2 |
| 6 | PREDNISOLONE ORAL | 2 |
| 7 | PREDNISOLONE ORAL SOLUTION | 2 |
| 8 | SILDENAFIL POWDER, | 2 |
| 9 | ABALOPARATIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | STANNOUS FLUORIDE | 1 | 0.0014 |
| 1 | NALOXONE HCL | 1 | 0.0012 |
| 2 | PSYLLIUM HUSK | 1 | 0.0007 |
| 3 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| 4 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 1 | 0.0002 |
| 5 | EPOPROSTENOL | 3 | 0.0002 |
| 6 | IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) | 1 | 0.0002 |
| 7 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0001 |
| 8 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | 1 | 0.0001 |
| 9 | PEGVALIASE-PQPZ | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 1 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 2 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 3 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 6 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 7 | Prostacycline Vasodilator [EPC] | 4 | 0.0000 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 3 | 0.0000 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |